Aimei Health Technology Co., Ltd.
Aimei Health Technology Co., Ltd.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||
Assets Current | |||||||||||||||
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Prepaid Expense Current | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Other Receivables | - | - | - | - | - | - | - | - | 0 | - | |||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Assets Held In Trust Noncurrent | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Assets | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Liabilities And Stockhold… | |||||||||||||||
Liabilities Current | |||||||||||||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Short Term Borrowings | 2 | 2 | 2 | 1 | 1 | 0 | - | - | - | - | |||||
Other Liabilities Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | - | - | |||||
Liabilities Current | 4 | 3 | 3 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | |||||
Redeemable Noncontrolling… | |||||||||||||||
Deferred Compensation Liability Classified Noncurr… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 4 | 4 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Temporary Equity Carrying Amount Attributable To P… | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Stockholders Equity | |||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -4 | -4 | -3 | -3 | -2 | -1 | -1 | -1 | -0 | -0 | |||||
Stockholders Equity | -4 | -4 | -3 | -3 | -2 | -1 | -1 | -1 | -0 | -0 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | 0 | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | 500 | |||||
Liabilities And Stockholders Equity | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Temporary Equity Shares Issued | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | |||||
Temporary Equity Shares Outstanding | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | |||||
Temporary Equity Redemption Price Per Share | 11.8 | 11.63 | 11.37 | 11.14 | 10.91 | 10.69 | 10.53 | 10.39 | 10.26 | 10.13 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Shares Outstanding | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Shares Subject To Mandatory Redemption Settlement … | 1 | 1 | 4 | 4 | 4 | 7 | 7 | 7 | 7 | 7 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -60.36% | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | 1.09% | 1.09% | 2.45% | 0.36% | 1.07% | 2.05% | 182.03% | 537.64% | 360.65% | -3.45% | -38.37% | - |
| 2024 | 0.19% | 0.61% | 0.78% | 0.38% | 0.77% | 1.15% | -0.39% | 0.37% | 1.02% | -0.06% | 1.39% | 1.39% |
| 2023 | - | - | - | - | - | - | - | - | - | 0.79% | 1.18% | 2.73% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Aimei Health Technology Co., Ltd. (AFJK) — SEC Financial Statements & Analysis
Aimei Health Technology Co., Ltd. (AFJK) is a blank checks company. Aimei Health Technology Co., Ltd. trades on Nasdaq as: AFJK, AFJKR, AFJKU. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Aimei Health Technology Co., Ltd. reported a Debt-to-Equity ratio of -1.00x, a Price-to-Book (P/B) ratio of -6.08 (TTM), at a market cap of $25.49M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.00x
- P/B TTM
- -6.08
- Market Cap
- $25.49M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Aimei Health Technology Co., Ltd. in?
Aimei Health Technology Co., Ltd. (AFJK) operates in the Blank Checks industry.
What is AFJK's market cap?
Aimei Health Technology Co., Ltd. (AFJK) has a market capitalization of $25.49M as of 2026-03-31.
What is AFJK's P/E ratio?
Aimei Health Technology Co., Ltd. (AFJK)'s trailing twelve month P/E ratio is 27.69x as of 2026-03-31.
What exchange does AFJK trade on?
Aimei Health Technology Co., Ltd. (AFJK) trades on the Nasdaq.